FDA approves vaccine for meningitis bacteria in children
June 15th, 2012
FDA approves GSK vaccine for meningitis-tied bacteria in young children
GlaxoSmithKline received FDA approval of MenHibrix, a vaccine against Haemophilus influenzae and Neisseria meningitidis in children as young as 6 weeks. These bacteria can lead to life-threatening conditions such as meningitis and infections in the blood. Crown Point Pediatrics will offer this new vaccine when insurance companies will cover the cost. Ask our providers about the availability of the MenHibrix vaccination for your child. MedCityNews.com (6/14)
David Roos, M.D.